Table 2.
Characteristics of the soya isoflavone interventions used in the randomised controlled trials examining the effect of equol producer (EP) status on the risk factors for CHD
First author, year | Source of isoflavones | Control | Isoflavone dose/d | Constituents of isoflavone dose | Duration of trial |
---|---|---|---|---|---|
Acharjee et al. (2015)(27)* | TLC diet with soya nuts | TLC diet without soya nuts | 101 mg isoflavones (AG)/d | 30 mg daidzein, 61 mg genistein, 10 mg glycitein | 16 weeks |
Badeau et al. (2007)(28)† | Isoflavone tablet | Placebo tablet | 114 mg isoflavones/d | 41 mg daidzein, 7 mg genistein, 66 mg glycitein | 6 months |
Campbell et al. (2004)(29) | Isoflavone tablet | Placebo tablet | 86 mg red clover isoflavones/d | 43 mg total isoflavones: 4 mg genistein, 5 mg daidzein, 25 mg biochanin, 8 mg formononetin | 2 months |
Clerici et al. (2007)(56) | Soya germ-enriched pasta | Conventional pasta | 33 mg of isoflavones (AG)/d | Predominantly daidzein, genistein, glycitein | 8 weeks |
Curtis et al. (2013)(30) | Flavonoid-enriched chocolate | Placebo chocolate | 100 mg isoflavones (AG)/d | Predominantly daidzein | 1 year |
Gallagher et al. (2004)(31) | SPI powder with isoflavones (SPI 96 or SPI 50) | SPI without isoflavones (SPI 4) | SPI 96: 96 mg/d isoflavones, SPI 50: 52 mg isoflavones/d | SPI 96: 28 mg daidzein, 52 mg genistein; SPI 50: 20 mg daidzein, 28 mg genistein; SPI 4: 0 mg daidzein, 4 mg genistein | 9 months (soya for 9 months, followed an additional 6 months) |
Gardner et al. (2007)(57) | WB milk, SPI milk | Dairy milk | WB: 125 (sd 17) isoflavones (AG)/d; SPI milk: 39 (sd 1) isoflavones (AG)/d | WB milk: 56·4 (sd 6·4) mg daidzein, 65·5 (sd 9·7) mg genistein, 2·9 (sd 0·4) mg glycitein; SPI milk: 12·9 (sd 0·2) mg daidzein, 24·7 (sd 0·3) mg genistein, 1·0 (sd 0·2) mg glycitein | 12 weeks |
Greany et al. (2004)(32)‡ | SPI, SPI plus probiotic capsules | MPI powder | 44 (sem 8) mg isoflavones/d | 34 % daidzein, 57 % genistein, 9 % glycitein | 24 weeks |
Greany et al. (2008)(33)‡ | SPI powder | MPI powder | 44 (sd 8) mg isoflavones/d | 34 % daidzein, 57 % genistein, 9 % glycitein | 24 weeks |
Hall et al. (2005)(34)§ | Isoflavone-enriched cereal bars | Placebo cereal bars | 50 mg isoflavones/d | Genistein:daidzein ratio of 2 | 16 weeks |
Hall et al. (2006)(35)§ | Isoflavone-enriched cereal bars | Placebo cereal bars | 50 mg isoflavones/d | Genistein:daidzein ratio of 2 | 16 weeks |
Hallund et al. (2006)(36)§ | Isoflavone-enriched cereal bars | Placebo cereal bars | 50 mg isoflavones/d | Genistein:daidzein ratio of 2 | 16 weeks |
Hodis et al. (2011)(14) | Powdered soya beverage or food bars | Total milk protein beverage or food bars | 91 mg isoflavones/d (154 mg total isoflavone conjugates plus AGs) | 36 mg AG daidzein 36 mg (61 mg total), 52 mg AG genistein (88 mg total), 3 mg AG glycitein (5 mg total) | 2·5–3 years |
Kreijkamp-Kaspers et al. (2005)(37)‖ | Soya protein powder | Total milk protein powder | 25·6 g of isoflavone-rich soya protein/d | 41 mg daidzein, 52 mg genistein, 6 mg glycitein (AG) in 36·5 g soya-protein powder | 12 months |
Kreijkamp-Kaspers et al. (2004)(38)‖ | Soya protein powder | Total milk protein powder | 25·6 g of isoflavone-rich soya protein/d | 41 mg daidzein, 52 mg genistein, 6 mg glycitein (AG) in 36·5 g soya-protein powder | 12 months |
Liu et al. (2014)(39)¶ | Whole soya group: soya flour; daidzein group: daidzein and milk powder | Low-fat milk powder | Whole soya group: 40 g soya with 49·8 mg total isoflavones/d; daidzein group: 63 mg daidzein/d | Whole soya group: 23·2 mg daidzein, 19·4 mg genistein; daidzein group: 63 mg daidzein | 6 months |
Liu et al. (2015)(40)¶ | Whole soya group: soya flour; daidzein group: daidzein and milk powder | Low-fat milk powder | Whole soya group: 49·3 mg isoflavones/d; daidzein group: 63 mg daidzein/d | Whole soya group: 23·2 mg daidzein, 19·4 mg genistein, 6·4 mg glycitein; daidzein group: 63 mg daidzein | 6 months |
Liu et al. (2013)(41)¶ | Whole soya group: soya flour; daidzein group: daidzein and milk powder | Low-fat milk powder | Whole soya group: 40 g soya with 49·8 mg total isoflavones/d; daidzein group: 63 mg daidzein/d | Whole soya group: 23·2 mg daidzein, 19·4 mg genistein, 6·7 mg glycitein; daidzein group: 63 mg daidzein | 6 months |
Ma et al. (2005)(58) | Soya protein powder | Milk protein powder | 120 mg isoflavones (AG)/d | Not reported | 5 weeks |
Mangano et al. (2013)(42) | SPI: soya protein and isoflavone tablets, SPP: soya protein and placebo tablets, CPI: control protein and isoflavone tablets | CPP: control protein and placebo tablets | Soya protein: 4 mg isoflavones/d; isoflavone tablets: 105 mg isoflavones (AG)/d | Primarily daidzein, genistein, glycitein and their β-glycosides | 1 year |
McVeigh et al. (2006)(67) | Low-Iso SPI: low-isoflavone SPI, high-Iso SPI: high-isoflavone SPI powders | MPI powder | Low-Iso SPI: 1·64 (sd 0·19) mg isoflavones (AG)/d; high-Iso SPI: 61·7 (sd 7·35) mg isoflavones (AG)/d | Not reported | 171 d |
Meyer et al. (2004)(59) | Soya milk, soya yogurt | Dairy milk, dairy yogurt | 80 mg isoflavones/d | Soya milk: 8·8 mg isoflavones/100 g, soya yogurt: 8·8 mg isoflavones/100 g | 10 weeks |
Nestel et al. (2004)(60) | Red clover pill (B or F preparations) | Placebo pill | 40 mg isoflavones/d of B or F preparations | Red clover B: <1 % daidzein, 4 % genistein, red clover F: <1 % daidzein and genistein | 12 weeks |
Nikander et al. (2004)(43)† | Isoflavonoid tablets | Placebo tablets | 114 mg isoflavonoids/d | 41 mg daidzein, 7 mg genistein, 66 mg glycitein | 6 months |
Pipe et al. (2009)(61) | SPI powder | MPI powder | 88 mg isoflavones (AG)/d | 27 mg daidzein, 57 mg genistein, 4 mg glycitein | 114 d |
Pop et al. (2008)(44) | Isoflavone capsules | Placebo capsule | 900 mg isoflavones/d | 296 mg daidzein, 558 mg genistein, 44 mg glycitein | 84 d |
Pusparini & Hidayat (2015)(45) | Soya isoflavone tablets | Placebo tablet | 40 mg isoflavones/d | 16·4 mg daidzein, 22·4 mg genistein, 1·2 mg glycitein | 6 months |
Qin et al. (2014)(62) | SPI with daidzein (DAI40 and DAI80) supplementation | SPI without daidzein supplementation | 0·7 mg isoflavones/d supplemented with 40 mg/d daidzein (DAI40) or 80 mg/d daidzein (DAI80) | DAI40: 40 mg daidzein, DAI80: 80 mg daidzein | 6 months |
Reimann et al. (2006)(46)§ | Isoflavone-enriched fruit cereal bars | Fruit cereal bar without isoflavones | 50 mg isoflavones/d | Genistein:daidzein ratio of 2:1 | 16 weeks |
Reverri et al. (2015)(63) | Soya nuts | Cookies supplemented with whey protein and fibre | 101 mg isoflavones (AG)/d | 42 mg daidzein, 55 mg genistein, 4 mg glycitein | 8 weeks |
Sen et al. (2012)(47) | High-soya group: two servings of soya foods/d; low-soya group: three servings of soya/week | None | High soya group: >40 mg of isoflavones/d; low soya group: <10 mg of isoflavones/d | Not reported | 12 months |
Steinberg et al. (2003)(48) | Soya+: SPI with isoflavones, soya-: SPI with trace amounts of isoflavones | Total milk protein | Soya+: 107·67 mg isoflavones/d (AG); soya−: 1·82 mg isoflavones/d (AG) | Soya+: 0·5 mg daidzein, 1 mg genistein, 0·5 mg glycitein (AG); soya-: 47 mg daidzein, 55 mg genistein, 5 mg glycitein (AG) | 18 weeks |
Thorp et al. (2008)(64) | Diet S: food with soya protein, diet SD: food with soya and dairy protein | Diet D: dairy protein | Diet S: 71·4 (sem 1·9) mg isoflavones (AG)/d; diet SD: 76 (sem 1·5) mg isoflavones (AG)/d; diet D: 0·5 (sem 0·1) mg isoflavones (AG)/d | Not reported | 18 weeks |
Törmälä et al. (2008)(49)** | Soya protein powder | Milk protein powder | 112 mg isoflavones (AG)/d | Not reported | 16 weeks |
Törmälä et al. (2008)(50)** | Soya protein powder | Milk protein powder | 112 mg isoflavones/d | 43 mg daidzein, 63 mg genistein, 6 mg glycitein | 16 weeks |
Törmälä et al. (2007)(51)** | Soya protein powder | Milk protein powder | 112 mg isoflavones/d | 43 mg daidzein, 63 mg genistein, 6 mg glycitein | 16 weeks |
Törmälä et al. (2006)(52)† | Isoflavone tablet | Placebo tablet | 114 mg isoflavones/d | 41 mg daidzein, 7 mg genistein, 66 mg glycitein | 6 months |
van der Velpen et al. (2014)(53) | Isoflavone capsule | Placebo capsule | Low genistein (LG): 100 mg isoflavones (AG)/d; high genistein (HG): 104 mg isoflavones/d | LG: 56 mg daidzein and daidzin, 16 mg genistein and genistin, 28 mg glycitein and glycitin; HG: 51 mg daidzein and daidzin, 43 mg genistein and genistin, 10 mg glycitein and glycitin | 16 weeks |
van der Velpen et al. (2013)(54) | Isoflavone capsule | Placebo capsule | 94 mg isoflavones (AG)/d | 56 mg daidzein, 12 mg genistein, 26 mg glycitein | 16 weeks |
Welty et al. (2007)(55)* | TLC diet with soya nuts | TLC diet without soya nuts | 101 mg isoflavones (AG)/d | 30 mg daidzein, 61 mg genistein, 10 mg glycitein | 16 weeks |
West et al. (2005)(65) | SPI powder | MPI powder | 90 mg isoflavones/d | Not reported | 12 weeks |
Wong et al. (2012)(66) | Soya food with isoflavones (three different diet protocols) | N/A | Low-isoflavone group: 10 mg/d; High-isoflavone group: 73 mg/d | Study 1: not reported; study 2: 28·4 mg daidzein, 29·7 mg genistein, 2·4 mg glycitein, study 3: not reported | 4–8 weeks |
TLC, therapeutic lifestyle changes; AG, aglycone; SPI, soya protein isolate; WB, whole bean soya; MPI, milk protein isolate; N/A, not applicable.
Studies that are or potentially using shared study participants.
Studies that are or potentially using shared study participants.
Studies that are or potentially using shared study participants.
Studies that are or potentially using shared study participants.
Studies that are or potentially using shared study participants.
Studies that are or potentially using shared study participants.
Studies that are or potentially using shared study participants.